SHL Telemedicine Ltd. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was USD 59 million compared to USD 49.58 million a year ago. Net loss was USD 0.076 million compared to USD 14.11 million a year ago.

Basic loss per share from continuing operations was USD 0.01 compared to USD 1 a year ago. Diluted loss per share from continuing operations was USD 0.48 compared to USD 1 a year ago.